CN114698717A - 一种调节肠功能的压片糖果 - Google Patents
一种调节肠功能的压片糖果 Download PDFInfo
- Publication number
- CN114698717A CN114698717A CN202210202315.9A CN202210202315A CN114698717A CN 114698717 A CN114698717 A CN 114698717A CN 202210202315 A CN202210202315 A CN 202210202315A CN 114698717 A CN114698717 A CN 114698717A
- Authority
- CN
- China
- Prior art keywords
- powder
- intestinal
- bifidobacterium
- oligosaccharide
- fructus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000003871 intestinal function Effects 0.000 title claims abstract description 19
- 235000009508 confectionery Nutrition 0.000 title claims abstract description 16
- 230000006870 function Effects 0.000 title description 12
- 239000000843 powder Substances 0.000 claims abstract description 134
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims abstract description 22
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims abstract description 20
- 244000134552 Plantago ovata Species 0.000 claims abstract description 17
- 235000003421 Plantago ovata Nutrition 0.000 claims abstract description 17
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims abstract description 17
- 229940107187 fructooligosaccharide Drugs 0.000 claims abstract description 17
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims abstract description 14
- 229920001202 Inulin Polymers 0.000 claims abstract description 13
- 229920002752 Konjac Polymers 0.000 claims abstract description 13
- UQZIYBXSHAGNOE-USOSMYMVSA-N Stachyose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO[C@@H]2[C@@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O2)O1 UQZIYBXSHAGNOE-USOSMYMVSA-N 0.000 claims abstract description 13
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims abstract description 13
- 229940029339 inulin Drugs 0.000 claims abstract description 13
- 210000000582 semen Anatomy 0.000 claims abstract description 13
- UQZIYBXSHAGNOE-XNSRJBNMSA-N stachyose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)O2)O)O1 UQZIYBXSHAGNOE-XNSRJBNMSA-N 0.000 claims abstract description 13
- 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 claims abstract description 12
- 229940009289 bifidobacterium lactis Drugs 0.000 claims abstract description 12
- 230000001105 regulatory effect Effects 0.000 claims abstract description 12
- 241000193749 Bacillus coagulans Species 0.000 claims abstract description 11
- 241001608472 Bifidobacterium longum Species 0.000 claims abstract description 11
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims abstract description 11
- 108090000790 Enzymes Proteins 0.000 claims abstract description 11
- 102000004190 Enzymes Human genes 0.000 claims abstract description 11
- 241000218588 Lactobacillus rhamnosus Species 0.000 claims abstract description 11
- 240000008042 Zea mays Species 0.000 claims abstract description 11
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims abstract description 11
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims abstract description 11
- 229940054340 bacillus coagulans Drugs 0.000 claims abstract description 11
- 229940009291 bifidobacterium longum Drugs 0.000 claims abstract description 11
- 239000002131 composite material Substances 0.000 claims abstract description 11
- 235000005822 corn Nutrition 0.000 claims abstract description 11
- 235000012055 fruits and vegetables Nutrition 0.000 claims abstract description 11
- 235000010485 konjac Nutrition 0.000 claims abstract description 11
- 235000010355 mannitol Nutrition 0.000 claims abstract description 11
- 239000000600 sorbitol Substances 0.000 claims abstract description 11
- 235000019359 magnesium stearate Nutrition 0.000 claims abstract description 10
- 239000002994 raw material Substances 0.000 claims abstract description 10
- 244000163122 Curcuma domestica Species 0.000 claims abstract description 9
- 241000167854 Bourreria succulenta Species 0.000 claims abstract description 8
- 235000003392 Curcuma domestica Nutrition 0.000 claims abstract description 8
- 244000179886 Moringa oleifera Species 0.000 claims abstract description 8
- 235000011347 Moringa oleifera Nutrition 0.000 claims abstract description 8
- 241000612118 Samolus valerandi Species 0.000 claims abstract description 8
- 235000019693 cherries Nutrition 0.000 claims abstract description 8
- 235000003373 curcuma longa Nutrition 0.000 claims abstract description 8
- 235000013976 turmeric Nutrition 0.000 claims abstract description 8
- 244000247812 Amorphophallus rivieri Species 0.000 claims abstract description 7
- 235000001206 Amorphophallus rivieri Nutrition 0.000 claims abstract description 7
- 239000000252 konjac Substances 0.000 claims abstract description 7
- 244000111489 Gardenia augusta Species 0.000 claims abstract description 6
- 244000185386 Thladiantha grosvenorii Species 0.000 claims abstract description 6
- 235000011171 Thladiantha grosvenorii Nutrition 0.000 claims abstract description 6
- 239000010903 husk Substances 0.000 claims abstract description 5
- 241000245665 Taraxacum Species 0.000 claims description 12
- 241000218236 Cannabis Species 0.000 claims description 10
- 241000186000 Bifidobacterium Species 0.000 claims description 7
- 235000013312 flour Nutrition 0.000 claims description 4
- 240000003291 Armoracia rusticana Species 0.000 claims description 3
- 235000011330 Armoracia rusticana Nutrition 0.000 claims description 3
- 239000009223 Psyllium Substances 0.000 abstract description 2
- 240000001949 Taraxacum officinale Species 0.000 abstract description 2
- 229940070687 psyllium Drugs 0.000 abstract description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 abstract 1
- 240000004308 marijuana Species 0.000 abstract 1
- 230000000968 intestinal effect Effects 0.000 description 29
- 206010010774 Constipation Diseases 0.000 description 26
- 230000000694 effects Effects 0.000 description 19
- 210000004369 blood Anatomy 0.000 description 15
- 239000008280 blood Substances 0.000 description 15
- 210000001035 gastrointestinal tract Anatomy 0.000 description 15
- 239000000047 product Substances 0.000 description 15
- 230000000052 comparative effect Effects 0.000 description 12
- 241000894006 Bacteria Species 0.000 description 10
- 230000036039 immunity Effects 0.000 description 10
- 238000002474 experimental method Methods 0.000 description 8
- 230000008855 peristalsis Effects 0.000 description 8
- 230000001737 promoting effect Effects 0.000 description 8
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 7
- 230000013872 defecation Effects 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 6
- 230000009102 absorption Effects 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 6
- 230000004060 metabolic process Effects 0.000 description 6
- ZFRKQXVRDFCRJG-UHFFFAOYSA-N skatole Chemical compound C1=CC=C2C(C)=CNC2=C1 ZFRKQXVRDFCRJG-UHFFFAOYSA-N 0.000 description 6
- 239000003053 toxin Substances 0.000 description 6
- 231100000765 toxin Toxicity 0.000 description 6
- 108700012359 toxins Proteins 0.000 description 6
- 206010012735 Diarrhoea Diseases 0.000 description 5
- 208000008589 Obesity Diseases 0.000 description 5
- 238000007599 discharging Methods 0.000 description 5
- 239000000835 fiber Substances 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 244000005700 microbiome Species 0.000 description 5
- 235000020824 obesity Nutrition 0.000 description 5
- 230000009286 beneficial effect Effects 0.000 description 4
- 235000013325 dietary fiber Nutrition 0.000 description 4
- 230000029087 digestion Effects 0.000 description 4
- 208000035475 disorder Diseases 0.000 description 4
- 210000003608 fece Anatomy 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 244000037364 Cinnamomum aromaticum Species 0.000 description 3
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 3
- 206010009944 Colon cancer Diseases 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 3
- 241000607764 Shigella dysenteriae Species 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 230000004888 barrier function Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 230000004600 colonic motility Effects 0.000 description 3
- 208000029742 colonic neoplasm Diseases 0.000 description 3
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 3
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 229940007046 shigella dysenteriae Drugs 0.000 description 3
- 229940074386 skatole Drugs 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 239000002699 waste material Substances 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- BAHMQESJBKGPTE-UHFFFAOYSA-N 1,5,8-trimethyl-3a,4-dihydroazuleno[6,5-b]furan-2,6-dione Chemical compound C1C2OC(=O)C(C)=C2C=C2C(C)=CC(=O)C2=C1C BAHMQESJBKGPTE-UHFFFAOYSA-N 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 208000035240 Disease Resistance Diseases 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 208000003351 Melanosis Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 239000003674 animal food additive Substances 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 210000001072 colon Anatomy 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 230000003467 diminishing effect Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 208000007784 diverticulitis Diseases 0.000 description 2
- 239000000147 enterotoxin Substances 0.000 description 2
- 231100000655 enterotoxin Toxicity 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 239000010794 food waste Substances 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 239000003906 humectant Substances 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 210000004347 intestinal mucosa Anatomy 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000006041 probiotic Substances 0.000 description 2
- 230000000529 probiotic effect Effects 0.000 description 2
- 235000018291 probiotics Nutrition 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 235000019605 sweet taste sensations Nutrition 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000033 toxigenic Toxicity 0.000 description 2
- 230000001551 toxigenic effect Effects 0.000 description 2
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 208000000197 Acute Cholecystitis Diseases 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- 244000025596 Cassia laevigata Species 0.000 description 1
- 235000006693 Cassia laevigata Nutrition 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010008570 Chloasma Diseases 0.000 description 1
- 206010008614 Cholecystitis acute Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- OMFXVFTZEKFJBZ-UHFFFAOYSA-N Corticosterone Natural products O=C1CCC2(C)C3C(O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 OMFXVFTZEKFJBZ-UHFFFAOYSA-N 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 235000014375 Curcuma Nutrition 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 208000017701 Endocrine disease Diseases 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010015967 Eye swelling Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- 208000032139 Halitosis Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 208000015710 Iron-Deficiency Anemia Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 206010023644 Lacrimation increased Diseases 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 201000009859 Osteochondrosis Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 235000006754 Taraxacum officinale Nutrition 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 201000009840 acute diarrhea Diseases 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000009414 anorectal function Effects 0.000 description 1
- 239000000729 antidote Substances 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 235000020980 bad eating habits Nutrition 0.000 description 1
- 230000002457 bidirectional effect Effects 0.000 description 1
- 210000003445 biliary tract Anatomy 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 230000036996 cardiovascular health Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 206010009887 colitis Diseases 0.000 description 1
- 230000000112 colonic effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- OMFXVFTZEKFJBZ-HJTSIMOOSA-N corticosterone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@H](CC4)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OMFXVFTZEKFJBZ-HJTSIMOOSA-N 0.000 description 1
- 235000012754 curcumin Nutrition 0.000 description 1
- 229940109262 curcumin Drugs 0.000 description 1
- 239000004148 curcumin Substances 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000000364 effect on atherosclerosis Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002888 effect on disease Effects 0.000 description 1
- 230000002892 effect on hypertension Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 208000030172 endocrine system disease Diseases 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 208000030533 eye disease Diseases 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 208000028774 intestinal disease Diseases 0.000 description 1
- 210000002490 intestinal epithelial cell Anatomy 0.000 description 1
- 230000007413 intestinal health Effects 0.000 description 1
- 230000008991 intestinal motility Effects 0.000 description 1
- 230000004317 lacrimation Effects 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 230000007659 motor function Effects 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 230000004693 neuron damage Effects 0.000 description 1
- 235000013615 non-nutritive sweetener Nutrition 0.000 description 1
- 235000019533 nutritive sweetener Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 210000003903 pelvic floor Anatomy 0.000 description 1
- 230000002572 peristaltic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 201000007094 prostatitis Diseases 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000009705 sanhuang Substances 0.000 description 1
- 230000036186 satiety Effects 0.000 description 1
- 235000019627 satiety Nutrition 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229940124513 senna glycoside Drugs 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 210000005070 sphincter Anatomy 0.000 description 1
- 230000008925 spontaneous activity Effects 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 230000001228 trophic effect Effects 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/48—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing plants or parts thereof, e.g. fruits, seeds, extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/364—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/364—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
- A23G3/366—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins containing microorganisms, enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/42—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds characterised by the carbohydrates used, e.g. polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/175—Rhamnosus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/531—Lactis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/533—Longum
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Polymers & Plastics (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Nutrition Science (AREA)
- Botany (AREA)
- Molecular Biology (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
本发明公开了一种调节肠功能的压片糖果，由以下质量份原料组成：山梨糖醇，D‑甘露糖醇，低聚果糖，菊粉，水苏糖，圆苞车前子壳粉，复合果蔬酵素粉，凝结芽孢杆菌，鼠李糖乳杆菌，乳双歧杆菌，长双歧杆菌，火麻仁粉，魔芋粉，栀子粉，姜黄，玉米须粉，蒲公英粉，葛根粉，郁李仁粉，决明子粉，罗汉果粉，辣木叶粉，硬脂酸镁，本发明压片糖果从调理机体的消化酶代谢，改善肠道微生态环境，使肠功能紊乱慢慢自行恢复，并且可以排出遗留在肠道皱壁上的宿便，使毒物吸收减少，起到调节免疫，改善新陈代谢，美白养颜功效。
Description
技术领域
本发明涉及保健食品领域，具体涉及一种调节肠功能的压片糖果。
背景技术
随着经济的发展，人们的生活节奏越来越快，生活压力也越来越大，不良饮食习惯和不良排便习惯的人越来越多，功能性便秘(排便费力、排便次数减少、排不尽感和粪便干结等)和肠功能减弱的人群越来越年轻化，人数越来越多。功能性便秘已经成为影响现代人生活质量的重要因素。
肠功能主要是吸收营养和排出食物残渣。正常肠功能下大便多为一天一到两次或两天一次，大便成形，为软便，排便顺畅干净。功能性便秘和肠功能减弱的表现为排便费力、排不尽感和粪便干结。功能性便秘分三种类型。第一种：慢传输型便秘又称结肠无力。是指结肠动力障碍以及结肠运动缓慢使内容物滞留在结肠所致的便秘。第二种：功能性出口梗阻型便秘，是患者直肠肛门功能异常。如排便时肛门括约肌不协调，排便反射缺如或盆底痉挛综合症所致。第三种：混合型便秘，即具有上述两型便秘的特点或两者均不典型。
调理肠功能的压片糖果主要是改善结肠动力障碍和出口梗阻，从而改善肠运动，使营养物质在小肠充分吸收的前提下，促进代谢废物尽快排出，改善排便费力、大便排不尽感和粪便干结分泌的现象，还可以使原有的积存在肠道皱壁上的宿便(黑便或棕绿色便)排出体外。起到清宿排毒，改善新陈代谢和调节免疫功能的目的。
目前市场上调理肠功能压片糖果的作用类似于番泻叶、果导片和三黄片等药物的腹泻作用的机理。特点是：服药即泄，便不成形，多为稀便，便不尽感，虽然短期内解决了排便问题，但让肠道慢慢失去了自主排便的功能，使肠功能减弱，肠蠕动减慢或消失，导致腹胀，排便不畅，大便淤积，从而因为肠功能的紊乱引起机体的消化、吸收、排泄、免疫等功能紊乱，进一步引起内分泌和代谢紊乱，出现月经失调，黄褐斑增多等现象。
发明内容
为解决上述技术问题，本发明提供的技术方案为：一种调节肠功能的压片糖果，由以下质量份原料组成：山梨糖醇5-40g，D-甘露糖醇5-40g，低聚果糖5-35g，菊粉3-20g，水苏糖3-20g，圆苞车前子壳粉3-20g，复合果蔬酵素粉3-20g，凝结芽孢杆菌0.5-10g，鼠李糖乳杆菌0.5-10g，乳双歧杆菌0.5-10g，长双歧杆菌0.5-10g，火麻仁粉0.5-10g，魔芋粉0.5-10g，栀子粉0.5-10g，姜黄0.5-10g，玉米须粉0.5-10g，蒲公英粉0.5-10g，葛根粉0.5-10g，郁李仁粉0.5-10g，决明子粉0.5-10g，罗汉果粉0.5-10g，辣木叶粉0.5-10g，硬脂酸镁0.5-20g。
优选地，由以下质量份原料组成：山梨糖醇7-37g，D-甘露糖醇7-37g，低聚果糖7-32g，菊粉5-18g，水苏糖5-18g，圆苞车前子壳粉5-18g，复合果蔬酵素粉5-18g，凝结芽孢杆菌3-9g，鼠李糖乳杆菌3-9g，乳双歧杆菌3-7g，长双歧杆菌3-7g，火麻仁粉3-7g，魔芋粉3-7g，栀子粉3-7g，姜黄3-7g，玉米须粉3-7g，蒲公英粉3-7g，葛根粉3-7g，郁李仁粉3-7g，决明子粉3-7g，罗汉果粉3-7g，辣木叶粉3-7g，硬脂酸镁3-7g。
优选地，由以下质量份原料组成：山梨糖醇17g，D-甘露糖醇12g，低聚果糖3g，菊粉10g，水苏糖10g，圆苞车前子壳粉2g，复合果蔬酵素粉2g，凝结芽孢杆菌5g，鼠李糖乳杆菌5g，乳双歧杆菌5g，长双歧杆菌5g，火麻仁粉0.5g，魔芋粉0.5g，栀子粉5g，姜黄5g，玉米须粉5g，蒲公英粉5g，葛根粉0.5g，郁李仁粉0.5g，决明子粉0.5g，罗汉果粉0.5g，辣木叶粉0.5g，硬脂酸镁0.5g。
山梨糖醇是营养性甜味剂、湿润剂、螯合剂和稳定剂；是一种具有保湿功能的特殊甜味剂；在人体内不转化为葡萄糖，不受胰岛素的控制，适合糖尿病人使用；
D-甘露糖醇是一种低热量甜味剂；胶姆糖及糖果的防粘剂；营养增补剂及组织改良剂；保湿剂；
低聚果糖可以预防便秘。低聚果糖是一种水溶性的膳食纤维，长期服用可以降低血清胆固醇、改善脂质，能够有效降低胆固醇和甘油三酯，对于因血脂升高而引起的高血压、动脉粥硬化也有比较好的改善作用；低聚果糖热能值不能被人体直接吸收，只能被肠道细菌吸收、利用，所以不会导致肥胖，对减肥也起到作用；低聚果糖可以促进生长发育和防止骨质疏松，同时可以促进维生素B族和叶酸的自然形成，提高人体的新陈代谢水平，提高免疫力和抗病力，预防和改善由体内毒素累积引起的皮肤性疾病。
菊粉可以控制血脂、降低血糖、促进矿物质的吸收、调节肠道微生物菌群、改善肠道健康、防止便秘、抑制有毒发酵产物的生成、保护肝脏、预防结肠癌、防便秘及治疗肥胖症膳食纤维减少食物在胃肠的停留时间、增加粪便量有效地治疗便秘，菊粉中有少量的2-9低聚果糖，研究表明，低聚果糖可使大脑神经细胞营养因子表达升高，对皮质酮诱导的神经元损作有很好的保护作用，具有良好的抗抑郁作用；
水苏糖可以润肠通便；水苏糖存在于自然界中的一种糖的化合物，其作用主要是可以改善小孩因为奶粉或者是消化功能弱所造成的便秘症状。老年患者由于气虚所导致的便秘症状也可服用水苏糖，可有效改善便秘；
圆苞车前子壳粉能够润肠通便；降低血胆固醇的功效；圆苞车前子纤维可用于防止/治疗便秘或腹泻，它可充分吸收水分，增大体积至可排泄团块，增加肠道蠕动，减少粪便在肠内运送时间，并逐渐变得有规律；预防结肠癌及其他肠胃疾病的罹患机率，纤维质可改变肠内微生物的种类及数目，另外，圆苞车前子纤维还发挥解毒剂的作用，过大量吸收水分和其他有害物质，增大粪便体积，使重金属和其他有害化学毒素被吸附在粪便团块内，从而降低致癌物或有害物质之浓度；同时，促进肠道蠕动，加速其排出，减少与肠壁粘膜接触的时间。因而可预防或降低结肠癌、大肠炎等肠道疾患之罹患机率；圆苞车前子纤维有助于控制饭后的血糖上升；圆苞车前子纤维使到达结肠内的物质体积增大，还能增加肠道的蠕动，减小对肠胃壁压力。这种调节作用有助于降低憩室炎的症状，甚至防止憩室炎的发病；控制体重，由于圆苞车前子壳含有丰富的水溶性纤维，遇水会膨胀形成数十倍的凝胶团，能增加饱足感，却不会提供热量，而且降低热量摄取。
复合果蔬酵素粉可以起到改善肠道功能的作用，具有促进胃肠道蠕动加速消化的功能；它还具有美容养颜的作用，对于青春期的人来说具有预防青春痘、色斑形成的作用，会让自己的皮肤变得更有水分；它还具有促进新陈代谢的作用；还具有降糖、血压、血脂的功效，从而预防肥胖的发生；还有提高人体的免疫力，预防某些疾病的发生。
凝结芽孢杆菌属芽孢杆菌属，细胞呈杆状，革兰氏(+)菌，端生芽孢，无鞭毛。它是一种益生菌、是活性菌，主要调节肠道的菌群，可以治疗因肠道菌群失调引起的急慢性腹泻，慢性便秘，腹胀和消化不良等；
鼠李糖乳杆菌能调节肠道菌群，LGG在人类肠道环境中定殖和繁殖后，仅仅是依附于宿主的肠上皮细胞，能够成为肠道粘膜的一层生物屏障，从而达到提升宿主肠道粘膜屏障能力；提升机体免疫力；预防和治疗腹泻；
乳双歧杆菌一种肠道的益生菌，可以抑制肠道内腐败菌的生长，同时在肠道里能够参与合成维生素B1、维生素B2、维生素B6和维生素K，对于人体有重要的作用。此外，乳双歧杆菌还可以促进食物的降解和吸收，能够预防缺铁性贫血或者骨软骨病；此外，乳双歧杆菌含有对人体的健康，产生生物屏障的作用，所以它具有一定的增强免疫力、抗肿瘤的作用；
长双歧杆菌是一种重要的肠道有益微生物，其作为一种生理性有益菌，对人体的健康十分重要；人体肠道内定植着大量微生物，肠道微生物与人体健康、疾病之间存在着十分密切的关系。正常情况下，人体内肠道微生物形成一个相对平衡的状态，一旦平衡被破坏，比如经常服用抗生素、放疗、化疗、免疫功能低下，都会导致肠道菌群失调，从而使许多有毒的物质产生过多，影响机体的健康；双歧杆菌和乳酸菌等有益菌能够抑制人体有害的细菌生长，抵抗病原菌的感染，合成人体所需的抗生素，促进人体对矿物质的吸收，刺激肠蠕动促进排便，防止便秘及抑制肠道腐败，净化肠道环境，刺激人体免疫系统，从而提高机体的抗病能力，都有着十分重要的作用；
火麻仁粉能够维持心血管健康，防止心血管病变更能降低中风与脑梗的发病率的作用；能够预防缓解便秘，治疗便秘；可以起到祛风除湿的作用，临床上用于人类风湿性关节炎的治疗；对人类肌肤有保护作用；
魔芋粉具有丰富的膳食纤维成分，因而能够促进肠道的蠕动，加速人体肠道堆积的毒素、脂肪等废物进行排出；具有丰富的膳食纤维成分，因而能够促进肠道的蠕动，加速人体肠道堆积的毒素、脂肪等废物进行排出；魔芋粉服用后可以针对人体进行调节，降低胆固醇、血脂以及须糖含量，同时具有扩张血管的作用，有效预防多种心脑血管疾病；魔芋粉具有很强的酸碱平衡能力，可以调节人体体质的酸碱度平衡，增强体质，保障人体健康。
栀子粉能够祛火除烦：适合热扰心魄；能够散血祛毒：用以血分热毒证；能够清泻寒湿：适用胆肝及下焦湿热证；
姜黄具有通经止痛、活血行气、驱寒消炎等功效；现代研究证实姜黄中的主要成分—姜黄素，具有抗氧化、抗肿瘤、降血脂、降血糖、抗溃疡、保护肝脏、抗心肌缺血、抗抑郁、抗菌、消炎、抗病毒和抗真菌等作用，可用于治疗癌症、糖尿病、冠心病、关节炎、阿尔茨海默氏病(早老性痴呆)以及其他慢性疾病；
玉米须粉味甘性平富含营养物质，不仅能增强人体的新陈代谢功能、还能调整人体的神经系统。玉米须粉可以利尿消肿、平肝利胆、降血压、止血等功能，治急、慢性肾炎、前列腺炎、水肿、急性胆囊炎、胆道结实和高血压等；
蒲公英粉药性偏寒，入肝、胃经，食用后对于热病、疮疡肿毒、目赤肿痛、湿热黄疸、小便淋沥涩痛、牙痛咽痛、热淋涩痛等症有不错的清热解毒功效；现代药理学研究发现，蒲公英中含有的抗菌成分对金黄色葡萄球菌、溶血性链球菌有较强的杀菌作用，对肺炎双球菌、白喉杆菌、绿脓杆菌、伤寒杆菌等也有一定杀菌作用；蒲公英中含有的蒲公英醇、蒲公英素、胆碱、有机酸、菊糖等多种成分，对内热炎症导致的尿路感染、排尿不畅具有一定的改善；
葛根粉味甘、性寒，含人体必需的锌、铁、钙、等微量元素及多种氨基酸，可以帮助提高人体免疫力。另外葛根粉具有祛火、滋阴、清热解毒、升阳生津、提高食欲等功效；
郁李仁粉能够润肠通便、利水消肿、破血消肿、下气消食；
决明子粉能够紧肤，减肥，排毒，降火，清肝，明目，利水，润肠通便；现代药理研究证实，决明茶辅助医药防治各种眼病(对眼睛红肿，流泪，干涩有特效)，高血压，高血脂(肥胖)和便秘也有明显效果，并且可调节和提高免疫力。取决明子粉10克加蜂蜜一起冲热水饮用，可减肥去脂，治疗便秘，对恢复脸色，去雀斑去口臭都有帮助；
罗汉果粉味甘、性凉，有清肺利咽、化痰止咳、润肠通便的作用；罗汉果中含有比蔗糖高300倍的甜味素，但不产生热量，适合肥胖、高血压、糖尿病等患者食用。罗汉果对于肾上腺素引起的肠管松弛有解痉和抵抗作用，让肠管自己恢复自发性活动，对肠管运动机能具有双向调节作用；
辣木叶粉中含有大量的维生素E、钙、蛋白质、钾等微量元素，可以降低血压、降低血脂和降低血糖、还可以增强机体的免疫力、增强体质、更有减肥的功效、可以促进代谢并排毒；
采用以上方案后，本发明具有如下优点：本发明压片糖果从调理机体的消化酶代谢，同时改善肠道微生态环境，使肠功能紊乱慢慢自行恢复，同时通过排出遗留在肠道皱壁上的宿便，使毒物吸收减少，起到调节免疫，改善新陈代谢，美白养颜功效。
附图说明
为了更清楚地说明本发明实施例的技术方案，下面将对实施例中所需要使用的附图作简单地介绍，应当理解的是，以下附图仅示出了本发明的某些实施例，因此不应被看作是对范围的限定。
图1是本发明实验一的结果示意图。
图2是本发明实验二的结果示意图。
图3是本发明实验三的结果示意图。
图4是本发明实验四的结果示意图。
具体实施方式
为使本发明实施例的目的、技术方案和优点更加清楚，下面将结合本发明实施例，对本发明实施例中的技术方案进行清楚、完整地描述，显然，所描述的实施例是本发明一部分实施例，而不是全部的实施例。
实施例一
一种调节肠功能的压片糖果，其特征在于，由以下质量份原料组成：山梨糖醇5-40g，D-甘露糖醇5-40g，低聚果糖5-35g，菊粉3-20g，水苏糖3-20g，圆苞车前子壳粉3-20g，复合果蔬酵素粉3-20g，凝结芽孢杆菌0.5-10g，鼠李糖乳杆菌0.5-10g，乳双歧杆菌0.5-10g，长双歧杆菌0.5-10g，火麻仁粉0.5-10g，魔芋粉0.5-10g，栀子粉0.5-10g，姜黄0.5-10g，玉米须粉0.5-10g，蒲公英粉0.5-10g，葛根粉0.5-10g，郁李仁粉0.5-10g，决明子粉0.5-10g，罗汉果粉0.5-10g，辣木叶粉0.5-10g，硬脂酸镁0.5-20g。
实施例二
一种调节肠功能的压片糖果，其特征在于，由以下质量份原料组成：山梨糖醇20g，D-甘露糖醇20g，低聚果糖5g，菊粉5g，水苏糖5g，圆苞车前子壳粉5g，复合果蔬酵素粉5g，凝结芽孢杆菌0.5g，鼠李糖乳杆菌0.5g，乳双歧杆菌0.5g，长双歧杆菌0.5g，火麻仁粉5g，魔芋粉2g，栀子粉0.5g，姜黄0.5g，玉米须粉0.5g，蒲公英粉0.5g，葛根粉5g，郁李仁粉5g，决明子粉5g，罗汉果粉5g，辣木叶粉2g，硬脂酸镁2g。
实施例三
山梨糖醇17g，D-甘露糖醇12g，低聚果糖3g，菊粉10g，水苏糖10g，圆苞车前子壳粉2g，复合果蔬酵素粉2g，凝结芽孢杆菌5g，鼠李糖乳杆菌5g，乳双歧杆菌5g，长双歧杆菌5g，火麻仁粉0.5g，魔芋粉0.5g，栀子粉5g，姜黄5g，玉米须粉5g，蒲公英粉5g，葛根粉0.5g，郁李仁粉0.5g，决明子粉0.5g，罗汉果粉0.5g，辣木叶粉0.5g，硬脂酸镁0.5g。
一、压片糖果制备
在制备时，按配方比例选取原料组分，将各原料组分混合均匀，制粒，压片为每粒1.0g，每次服用3-6片，每日1-2次。
二、实验案例
1、实验一
准备实验例与对比例，其中，实验例将本产品与双歧杆菌共同培养，对比例将双歧杆菌单独培养，观察实验例与对比例的生长曲线，结合附图1，根据结果可以看出，本产品能够明显促进双歧杆菌的生长繁殖。
2、实验二
准备实验例一、实验例二、实验例三以及对比例一、对比例二、对比三，实验例一为将本产品与大肠杆菌共同培养，实验例二为将本产品与伤寒沙门氏菌共同培养，实验例三为将本产品与痢疾志贺菌共同培养；对比例一为将大肠杆菌单独培养，对比例二为将伤寒伤寒沙门氏菌单独培养，对比例三为将痢疾志贺菌单独培养；观察实验例一、实验例二、实验例三、对比例一、对比例二、对比例三的生长曲线，结合附图2，根据结果可以看出，本产品有效拮抗肠出血性大肠杆菌、痢疾志贺菌、伤寒伤寒沙门氏菌等场内有害产毒菌，消除产毒源，并分解食物残渣中的多聚糖为低聚糖，促进双岐杆菌等肠道有益菌协同繁殖，快速恢复肠道菌群平衡。
3、实验三
选择多名的实验人员，使实验人员连续14天服用本产品，检测实验人员服用前、服用14天后大便中吲哚含量、粪臭素含量，结合附图3，根据结果可以看出，口服产品14天后大便中吲哚含量下降40.39％，粪臭素含量下降50.46％，说明方便果能显著降低肠道中吲哚、粪臭素等肠毒素的含量，从而消除了肠毒素对肠道的毒害。
4、实验四
选择多名的实验人员，将其分为三组，实验一组连续服用本产品14天，实验二组连续服用本产品28天，对照组不服用本产品，结合附图4，根据结果可知，服用产品28后的显效率和总有效率显著高于服用14天，说明肠道菌群和肠动力恢复需要一个过程。
以上对本发明及其实施方式进行了描述，这种描述没有限制性，附图中所示的也只是本发明的实施方式之一，实际的结构并不局限于此。总而言之如果本领域的普通技术人员受其启示，在不脱离本发明创造宗旨的情况下，不经创造性的设计出与该技术方案相似的结构方式及实施例，均应属于本发明的保护范围。
Claims (3)
1.一种调节肠功能的压片糖果，其特征在于，由以下质量份原料组成：山梨糖醇5-40g，D-甘露糖醇5-40g，低聚果糖5-35g，菊粉3-20g，水苏糖3-20g，圆苞车前子壳粉3-20g，复合果蔬酵素粉3-20g，凝结芽孢杆菌0.5-10g，鼠李糖乳杆菌0.5-10g，乳双歧杆菌0.5-10g，长双歧杆菌0.5-10g，火麻仁粉0.5-10g，魔芋粉0.5-10g，栀子粉0.5-10g，姜黄0.5-10g，玉米须粉0.5-10g，蒲公英粉0.5-10g，葛根粉0.5-10g，郁李仁粉0.5-10g，决明子粉0.5-10g，罗汉果粉0.5-10g，辣木叶粉0.5-10g，硬脂酸镁0.5-20g。
2.根据权利要求1所述的一种调节肠功能的压片糖果，其特征在于，由以下质量份原料组成：山梨糖醇7-37g，D-甘露糖醇7-37g，低聚果糖7-32g，菊粉5-18g，水苏糖5-18g，圆苞车前子壳粉5-18g，复合果蔬酵素粉5-18g，凝结芽孢杆菌3-9g，鼠李糖乳杆菌3-9g，乳双歧杆菌3-7g，长双歧杆菌3-7g，火麻仁粉3-7g，魔芋粉3-7g，栀子粉3-7g，姜黄3-7g，玉米须粉3-7g，蒲公英粉3-7g，葛根粉3-7g，郁李仁粉3-7g，决明子粉3-7g，罗汉果粉3-7g，辣木叶粉3-7g，硬脂酸镁3-7g。
3.根据权利要求1所述的一种调节肠功能的压片糖果，其特征在于，由以下质量份原料组成：山梨糖醇17g，D-甘露糖醇12g，低聚果糖3g，菊粉10g，水苏糖10g，圆苞车前子壳粉2g，复合果蔬酵素粉2g，凝结芽孢杆菌5g，鼠李糖乳杆菌5g，乳双歧杆菌5g，长双歧杆菌5g，火麻仁粉0.5g，魔芋粉0.5g，栀子粉5g，姜黄5g，玉米须粉5g，蒲公英粉5g，葛根粉0.5g，郁李仁粉0.5g，决明子粉0.5g，罗汉果粉0.5g，辣木叶粉0.5g，硬脂酸镁0.5g。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210202315.9A CN114698717A (zh) | 2022-03-03 | 2022-03-03 | 一种调节肠功能的压片糖果 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210202315.9A CN114698717A (zh) | 2022-03-03 | 2022-03-03 | 一种调节肠功能的压片糖果 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN114698717A true CN114698717A (zh) | 2022-07-05 |
Family
ID=82167507
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202210202315.9A Pending CN114698717A (zh) | 2022-03-03 | 2022-03-03 | 一种调节肠功能的压片糖果 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114698717A (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116172193A (zh) * | 2022-05-09 | 2023-05-30 | 内蒙古悦农生物科技有限公司 | 一种润肠通便的组合物及其制备方法和用途 |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102524649A (zh) * | 2012-03-07 | 2012-07-04 | 杜小岗 | 低聚木糖果多糖片 |
| CN107136279A (zh) * | 2017-05-27 | 2017-09-08 | 广州泽成生物科技有限公司 | 一种乳酸菌压片糖果及其制备方法 |
| CN110269251A (zh) * | 2019-07-23 | 2019-09-24 | 天津国民健康技术有限公司 | 一种通便促排的组合物及其制备方法 |
| CN112544920A (zh) * | 2020-12-03 | 2021-03-26 | 山东腾贵医药有限公司 | 一种改善便秘的组合物及其制备方法 |
| CN114097917A (zh) * | 2021-10-15 | 2022-03-01 | 山东星光首创生物科技有限公司 | 一种润肠通便的压片糖果及其制备方法 |
-
2022
- 2022-03-03 CN CN202210202315.9A patent/CN114698717A/zh active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102524649A (zh) * | 2012-03-07 | 2012-07-04 | 杜小岗 | 低聚木糖果多糖片 |
| CN107136279A (zh) * | 2017-05-27 | 2017-09-08 | 广州泽成生物科技有限公司 | 一种乳酸菌压片糖果及其制备方法 |
| CN110269251A (zh) * | 2019-07-23 | 2019-09-24 | 天津国民健康技术有限公司 | 一种通便促排的组合物及其制备方法 |
| CN112544920A (zh) * | 2020-12-03 | 2021-03-26 | 山东腾贵医药有限公司 | 一种改善便秘的组合物及其制备方法 |
| CN114097917A (zh) * | 2021-10-15 | 2022-03-01 | 山东星光首创生物科技有限公司 | 一种润肠通便的压片糖果及其制备方法 |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116172193A (zh) * | 2022-05-09 | 2023-05-30 | 内蒙古悦农生物科技有限公司 | 一种润肠通便的组合物及其制备方法和用途 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6203797B1 (en) | Dietary supplement and method for use as a probiotic, for alleviating the symptons associated with irritable bowel syndrome | |
| CN106954847A (zh) | 具有润肠通便功能的酵素益生菌组合物、应用及加工制剂 | |
| CN105341906A (zh) | 糖尿病医学配方食品 | |
| CN107496850A (zh) | 一种调节肠道微生态制剂的配方及应用 | |
| CN104223074A (zh) | 便秘全营养配方食品 | |
| CN102861108B (zh) | 一种用于治疗便秘的药物组合物及其应用 | |
| CN102657794A (zh) | 用于预防和治疗鸡白痢的中药、制备方法和饲料 | |
| CN109718289A (zh) | 一种治疗或预防胃肠道疾病的低聚半乳糖益生元组合物 | |
| CN104161263B (zh) | 儿童全营养配方食品 | |
| CN105029393A (zh) | 儿童医学配方食品 | |
| CN108402371A (zh) | 一种适合中老年便秘人群服用的益生元组合物 | |
| CN114698717A (zh) | 一种调节肠功能的压片糖果 | |
| KR102000170B1 (ko) | 체지방 감소 및 장관면역활성 증진을 위한 건강보조식품 | |
| CN104187642A (zh) | 前列腺炎全营养配方食品 | |
| CN104146267B (zh) | 红斑狼疮全营养配方食品 | |
| CN115844019A (zh) | 一种能够调节肠道的益生菌及应用 | |
| CN114158735B (zh) | 一种益生菌组合物及其应用 | |
| CN104146266A (zh) | 调理黄褐斑的全营养配方食品 | |
| CN104187650A (zh) | 特禀体质全营养配方食品 | |
| CN114343180A (zh) | 一种具有通腑排毒作用的系列组合物及其应用 | |
| KR100437933B1 (ko) | 변비 및 장기능 개선 효과를 갖는 건강보조식품 및 이의조성물 | |
| KR100484428B1 (ko) | 변비 개선용 건강 보조 식품 | |
| CN113769029A (zh) | 一种改善肠道吸收、免疫功能的药食同源本草组合物 | |
| CN104116999A (zh) | 改善肠道微生物环境的制剂及其制备方法 | |
| CN104839650A (zh) | 宫颈癌医学配方食品 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |